Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings Inc


Market Cap$352.85M

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Xeris Biopharma Holdings IncXeris Biopharma Holdings Inc-5.50%-2.4-

Target Price by Analysts

24.5% upsideXeris Biopharma Holdings Target Price DetailsTarget Price

Current Fair Value

20% upside

Undervalued by 20% based on the discounted cash flow analysis.

Share Statistics

Market cap$352.85 Million
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.46
Outstanding Shares148,255,663
Avg 30 Day Volume1,227,140


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-5.48
Price to Sales2.41
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income0
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Xeris Pharmaceuticals Inc

CEO: paul Edick